NR3C2 and liver dysplastic nodule: In addition, the phase 2B study, MinerAlocorticoid Receptor antagonist Tolerability Study-Diabetic Nephropathy (ARTS-DN), compared the effectiveness of nonsteroidal MRA—finerenone in different doses to placebo in DN.